Document Detail


Peptide and recombinant immunotherapy.
MedLine Citation:
PMID:  21530826     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Because of the need to standardize allergen immunotherapy and the desire to reduce allergic adverse events during therapy, a transition to recombinant/synthetic hypoallergenic approaches is inevitable. Evidence supports the notion that effective therapy can be delivered using a limited panel of allergens or even epitopes, weakening the argument that all allergens must be present for optimal efficacy. Moreover, standardized products will allow direct comparisons between studies and, for the first time, immunotherapy studies will be truly blinded, allowing an accurate assessment of the actual treatment effect that can be achieved with this form of intervention.
Authors:
Mark Larché
Related Documents :
19197576 - Spinal decompression sickness presenting as partial brown-sequard syndrome and treated ...
19945106 - The effects of chinese calligraphy handwriting and relaxation training in chinese nasop...
7586966 - A barium enema training programme for radiographers: a pilot study.
870536 - A programmed training technique that uses reinforcement to facilitate acquisition and r...
21763936 - Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults...
23179746 - The associations between personality characteristics and absenteeism: a cross-sectional...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Immunology and allergy clinics of North America     Volume:  31     ISSN:  1557-8607     ISO Abbreviation:  Immunol Allergy Clin North Am     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-05-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8805635     Medline TA:  Immunol Allergy Clin North Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  377-89     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Affiliation:
Department of Medicine, Firestone Institute for Respiratory Health, McMaster University, HSC 4H20, 1200 Main Street West, Hamilton, ON L8N 3Z5, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Oral desensitization for food hypersensitivity.
Next Document:  Novel administration routes for allergen-specific immunotherapy: a review of intralymphatic and epic...